http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109081813-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate | 2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109081813-B |
| titleOfInvention | Benzoheterocycles compounds and application thereof in treating cancers |
| abstract | The invention discloses a benzo-heterocyclic compound shown in a formula I, or a pharmaceutically acceptable salt, a crystal form, a solvate, an isotopologue, a tautomer or a stereochemical isomer thereof. The experimental result shows that the compound can obviously reduce the expression of full-length androgen receptor (AR-FL) and variant androgen receptor (AR-v7), inhibit the proliferation of cancer cells, especially prostate cancer cells, and has potential therapeutic effect on cancer, especially prostate cancer. |
| priorityDate | 2017-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.